HR

Hartmut Rehwinkel

BP Bayer Pharma: 4 patents #15 of 244Top 7%
AA Astrazeneca Ab: 1 patents #20 of 133Top 20%
BG Bayer Intellectual Property Gmbh: 1 patents #18 of 138Top 15%
Overall (2018): #29,266 of 503,207Top 6%
5
Patents 2018

Issued Patents 2018

Showing 1–5 of 5 patents

Patent #TitleCo-InventorsDate
10137110 1-cyclohexyl-2-phenylaminobenzimidazoles as mIDH1 inhibitors for the treatment of tumors Sonja Anlauf, Duy Nguyen, Olaf Panknin, Marcus Bauser, Katja Zimmermann +4 more 2018-11-27
10138226 Benzimidazol-2-amines as MIDH1 inhibitors Marcus Bauser, Katja Zimmermann, Stefan Kaulfuß, Roland Neuhaus 2018-11-27
RE47047 5-[(3,3,3-trifluoro-2-hydroxy-1-arylpropyl)amino]-1H-quinolin-2-ones, a process for their production and their use as anti-inflammatory agents Markus Berger, Thomas Zollner, Ekkehard May, Jorma Hassfeld, Heike Schaecke 2018-09-18
9957235 Benzimidazol-2-amines as mIDH1 inhibitors Olaf Panknin, Sven Ring, Sonja Anlauf, Holger Siebeneicher, Duy Nguyen +6 more 2018-05-01
9951027 Benzimidazol-2-amines as MIDH1 inhibitors Holger Siebeneicher, Sonja Anlauf, Duy Nguyen, Olaf Panknin, Sven Ring +5 more 2018-04-24